From the Cole Eye Institute (BKA, VA, WJD, MRF, GHG, MPL, ASR, MRS, VS, SEW); and Quantitative Health Sciences, Cleveland Clinic (RSB), Cleveland, Ohio.
Supported in part by US Public Health Service grants EY010056 and EY015638 from the National Eye Institute and Research to Prevent Blindness, New York, New York, and an RPB Career Development Award (WJD).
Dr. Dupps has received honorarium funds from Zeimer related to the Galilei Dual Scheimpflug Analyzer (Ziemer, Port, Switzerland) and sponsored research funds from the companies involved in riboflavin-ultraviolet A cross-linking trials (Topcon, Oakland, New Jersey, and Avedro, Waltham, Massachusetts) and has patented optical coherence tomography elastography. The remaining authors have no financial or proprietary interest in the materials presented herein.
The authors thank Ronald Krueger, MD, for his assistance in producing corneal pockets for femtosecond laser-assisted transepithelial corneal cross-linking.
Study concept and design (BKA, MPL, ASR, WJD, SEW); data collection (BKA, MPL, MRF, MRS, VS, GHG, VA, ASR, WJD, SEW); analysis and interpretation of data (BKA, MPL, MRF, MRS, VS, GHG, ASR, RSB, WJD, SEW); drafting of the manuscript (BKA, MPL, MRF, WJD, SEW); critical revision of the manuscript (BKA, MPL, MRF, MRS, VS, GHG, VA, ASR, RSB, WJD, SEW); statistical expertise (RSB); obtained funding (WJD, SEW); administrative, technical, or material support (SEW); supervision (WJD, SEW)
Correspondence: Steven E. Wilson, MD, Cole Eye Institute, I-32, Cleveland Clinic, 9500 Euclid Ave., Cleveland, OH 44195. E-mail: firstname.lastname@example.org